| 1. |  4D Pharma plc Leeds, United Kingdom | Biotech | Preclinical to Phase II (at time of administration) | VIEW |
| 2. |  AGS Therapeutics Paris, France | Biotech | Preclinical | VIEW |
| 3. |  | Biotech | Phase 3 | VIEW |
| 4. |  Abzena Cambridge, United Kingdom | CDMO | Commercial | VIEW |
| 5. |  Advanced Clinical Deerfield, Illinois, USA | CRO | Commercial | VIEW |
| 6. |  Affitech Copenhagen, Denmark (with R&D in Oslo, Norway and San Francisco, USA) | Biotech | Clinical | VIEW |
| 7. |  Agostino Gemelli University Hospital Rome, Italy | CRO | Phase 1-4 | VIEW |
| 8. |  Aico Worldwide Boston, USA | Digital Health | Commercial | VIEW |
| 9. |  Ajou University Suwon, South Korea | Biotech | Phase 3 | VIEW |
| 10. |  Akkodis Zurich, Switzerland | CRO | Commercial | VIEW |
| 11. |  Allucent Cary, North Carolina, USA | CRO | Commercial | VIEW |
| 12. |  Allygen Biosciences Shanghai, China | Biotech | Preclinical | VIEW |
| 13. |  Almac Group Craigavon, United Kingdom | CDMO | Discovery | VIEW |
| 14. |  Altasciences Laval, Quebec, Canada | CRO | Preclinical to Phase II (early-phase development) | VIEW |
| 15. |  Amgen Thousand Oaks, California, United States | Pharma | Discovery through Commercial | VIEW |
| 16. |  Anthem Biosciences Bangalore, India | CDMO | Commercial | VIEW |
| 17. |  Arcus Biosciences Hayward, United States | Biotech | Phase 3 | VIEW |
| 18. |  Artica Therapeutics Leiden, Netherlands | Biotech | Preclinical | VIEW |
| 19. |  AskGene Camarillo, California, United States | Biotech | Phase 3 | VIEW |
| 20. |  Astellas Pharma Inc. Tokyo, Japan | Pharma | Discovery to Phase 3 | VIEW |
| 21. |  Aurigene Pharmaceutical Services Limited Bengaluru, India | CDMO | Commercial | VIEW |
| 22. |  Autolus Therapeutics London, United Kingdom | Biotech | Commercial + Phase 1/2 | VIEW |
| 23. |  BASF Ludwigshafen, Germany | Pharma | Commercial | VIEW |
| 24. |  BC Platforms Zurich, Switzerland | Digital Health | Commercial | VIEW |
| 25. |  | Pharma | Discovery through Commercial | VIEW |
| 26. |  BenevolentAI London, United Kingdom | Biotech | Phase 1|Phase 2|Preclinical | VIEW |
| 27. |  | CDMO | Commercial | VIEW |
| 28. |  BioChain Institute Inc. Newark, California, USA | Diagnostics | Commercial | VIEW |
| 29. |  BioMed Valley Discoveries Kansas City, Missouri, USA | Biotech | Clinical (Phase 1-2) | VIEW |
| 30. |  Biocon Limited Bengaluru, India | Pharma | Commercial, Phase 3, Phase 2, Phase 1 | VIEW |
| 31. |  Bionorica SE Neumarkt in der Oberpfalz, Germany | Pharma | Commercial | VIEW |
| 32. |  BlueRock Therapeutics Cambridge, USA | Biotech | Phase 3 | VIEW |
| 33. |  Boehringer Ingelheim Ingelheim am Rhein, Germany (near Mainz and Frankfurt) | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 34. |  Boostimmune Seoul, South Korea | Biotech | Preclinical | VIEW |
| 35. |  Bristol Myers Squibb Princeton, New Jersey, United States | Pharma | Phase 1-3 and Commercial | VIEW |
| 36. |  | Digital Health | Commercial | VIEW |
| 37. |  CDR-Life Schlieren, Zurich, Switzerland | Biotech | Phase 1 | VIEW |
| 38. |  CEMKA Bourg-la-Reine, France | CRO | Commercial | VIEW |
| 39. |  CHUV (Centre Hospitalier Universitaire Vaudois) Lausanne, Switzerland | Biotech | Phase 3 | VIEW |
| 40. |  CSL Limited Melbourne, Australia | Pharma | Commercial | VIEW |
| 41. |  CSL Limited (CSL Behring is the largest division) Melbourne, Australia (corporate); King of Prussia, USA (CSL Behring) | Pharma | Phase 1 through Commercial | VIEW |
| 42. |  Cadence Design Systems San Jose, USA | Digital Health | Commercial | VIEW |
| 43. |  Caldera Therapeutics Cambridge, USA | Biotech | Phase 1 | VIEW |
| 44. |  Calico Life Sciences South San Francisco, United States | Biotech | Phase 2 | VIEW |
| 45. |  | Biotech | Phase 1 - Phase 2 | VIEW |
| 46. |  Carelon Research Wilmington, Delaware, USA | CRO | Commercial | VIEW |
| 47. |  Cellares South San Francisco, USA | CDMO | Commercial | VIEW |
| 48. |  Celltrion Incheon, South Korea | Pharma | Commercial | VIEW |
| 49. |  Celon Pharma Łomianki, Poland | Biotech | Phase 3 | VIEW |
| 50. |  Center of Molecular Immunology (CIM) Havana, Cuba | Biotech | Commercial | VIEW |
| 51. |  Centrexion Therapeutics Boston, Massachusetts, United States | Biotech | Phase 1-3 | VIEW |
| 52. |  Cerebras Systems Sunnyvale, USA | Digital Health | Commercial | VIEW |
| 53. |  Charles River Laboratories Wilmington, Massachusetts, USA | CRO | Commercial | VIEW |
| 54. |  Charles River Laboratories Wilmington, Massachusetts, USA | CRO | Commercial | VIEW |
| 55. |  Chiba University Chiba, Japan | Biotech | Phase 2 | VIEW |
| 56. |  China Medical University Hospital (CMUH) Taichung, Taiwan | Biotech | Phase 2 | VIEW |
| 57. |  Chong Kun Dang Pharmaceutical Corp. Seoul, South Korea | Pharma | Commercial | VIEW |
| 58. |  Choose Life Biotech SA Bellinzona, Switzerland | Biotech | Preclinical | VIEW |
| 59. |  Chugai Pharma Taiwan Ltd. Taipei, Taiwan | Pharma | Commercial | VIEW |
| 60. |  Chung-Ang University Seoul, South Korea | Biotech | Phase 3 | VIEW |
| 61. |  Cincinnati Children's Hospital Medical Center Cincinnati, USA | Biotech | Commercial | VIEW |
| 62. |  Circio Holding ASA Lysaker, Norway | Biotech | Phase 1/2 | VIEW |
| 63. |  Clinical Horizons Research Inc. Leonia, New Jersey, USA | CRO | Commercial | VIEW |
| 64. |  Clinical Process Services (CPS) Dubai, United Arab Emirates | CRO | Commercial | VIEW |
| 65. |  Clinical2Digital San Diego, USA | Digital Health | Commercial | VIEW |
| 66. |  Crixmor LLC Malvern, Pennsylvania, USA | Biotech | Discovery | VIEW |
| 67. |  | Biotech | Phase 1 | VIEW |
| 68. |  Cullinan Therapeutics Cambridge, USA | Biotech | Phase 3 | VIEW |
| 69. |  CuraTeQ Biologics Hyderabad, India | Biotech | Commercial | VIEW |
| 70. |  CuraVac Rixensart, Belgium | Biotech | Phase 1B (completed) | Phase 2 (in preparation) | VIEW |
| 71. |  Curadev Pharma Pvt Ltd Noida, India | Biotech | Phase 1 | VIEW |
| 72. |  | CRO | Service Provider | VIEW |
| 73. |  Cytel Cambridge, Massachusetts, USA | CRO | N/A - Service Provider | VIEW |
| 74. |  Cytiva Marlborough, Massachusetts, USA | MedTech | Commercial | VIEW |
| 75. |  CytoAgents Pittsburgh, USA | Biotech | Phase 2 | VIEW |
| 76. |  CytoDyn Inc Vancouver, Washington | Biotech | Phase 2 clinical | VIEW |
| 77. |  CytoImmune Therapeutics Duarte, USA | Biotech | Phase 1 | VIEW |
| 78. |  CytoSen Therapeutics Orlando (Winter Springs), Florida, USA | Biotech | Phase 2 | VIEW |
| 79. |  Cytonics Corporation Jupiter, Florida, USA | Biotech | Phase 2 | VIEW |
| 80. |  Cytonus Therapeutics Carlsbad, California, United States | Biotech | Phase 1 | VIEW |
| 81. |  Cytovance Biologics Oklahoma City, USA | CDMO | Commercial | VIEW |
| 82. |  Cytovia Therapeutics Aventura, Florida, USA | Biotech | Phase 1/2 | VIEW |
| 83. |  | Biotech | Phase 2 | VIEW |
| 84. |  DBV Technologies Châtillon, France | Biotech | Phase 3 | VIEW |
| 85. |  Daewoong Pharmaceutical Seoul, South Korea | Pharma | Commercial | VIEW |
| 86. |  Daiichi Sankyo Chuo, Tokyo, Japan | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 87. |  Development Center for Biotechnology (DCB) Taipei, Taiwan | Biotech | Preclinical | VIEW |
| 88. |  Dolor Therapeutics, Inc. Chicago, USA | Biotech | Preclinical | VIEW |
| 89. |  Dr. Reddy's Laboratories Ltd. Hyderabad, India | Pharma | Commercial | VIEW |
| 90. |  Duality Biologics Shanghai, China | Biotech | Phase 3 | VIEW |
| 91. |  EEE Pharma Maharashtra, India | Biotech | Commercial | VIEW |
| 92. |  ELIQUENT Life Sciences Washington, DC, USA | CRO | Commercial | VIEW |
| 93. |  ENGEDI RX Roswell, Georgia, USA | CRO | Commercial | VIEW |
| 94. |  ETH Zürich Zurich, Switzerland | Biotech | Discovery | VIEW |
| 95. |  EVERSANA Chicago, Illinois, USA | CRO | Commercial | VIEW |
| 96. |  EY Global Delivery Services (GDS) London, United Kingdom | CRO | Late Stage | VIEW |
| 97. |  Ecolab Inc. Saint Paul, USA | Pharma | Commercial | VIEW |
| 98. |  Efficient Pharma Management Corp. (EffPha) Taipei City, Taiwan | CRO | Commercial | VIEW |
| 99. |  EirGenix, Inc. New Taipei City, Taiwan | CDMO | Commercial | VIEW |
| 100. |  Eledon Pharmaceuticals Irvine, USA | Biotech | Phase 2 | VIEW |
| 101. |  Elevance Health Indianapolis, USA | Digital Health | Commercial | VIEW |
| 102. |  Eli Lilly and Company Indianapolis, Indiana, USA | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 103. |  Enlivex Therapeutics Ltd. Ness Ziona, Israel | Biotech | Phase 2 | VIEW |
| 104. |  | Biotech | Preclinical | VIEW |
| 105. |  Escientia Life Sciences South Windsor, Connecticut, USA | CDMO | Commercial | VIEW |
| 106. |  EurimPharm Arzneimittel GmbH Saaldorf-Surheim, Germany | Biotech | Commercial | VIEW |
| 107. |  European Medicines BV Lelystad, Netherlands | CRO | Commercial | VIEW |
| 108. |  Evernorth Health Services St. Louis, USA | Digital Health | Commercial | VIEW |
| 109. |  Evolution Health Group, LLC Pearl River, New York, USA | CRO | Commercial | VIEW |
| 110. |  Evotec SE Hamburg, Germany | Biotech | Commercial | VIEW |
| 111. |  Export-Import Bank of Korea Seoul, South Korea | Pharma | Commercial | VIEW |
| 112. |  | CDMO | Commercial | VIEW |
| 113. |  FFF Enterprises, Inc. Temecula, USA | CDMO | Commercial | VIEW |
| 114. |  FNCT Biotech Seongnam-si, South Korea | Biotech | Preclinical | VIEW |
| 115. |  | Pharma | Commercial | VIEW |
| 116. |  Fidelity Investments Boston, USA | Pharma | Commercial | VIEW |
| 117. |  Formation Bio New York, USA | Biotech | Phase 3 | VIEW |
| 118. |  Formycon AG Planegg-Martinsried, Germany | Biotech | Commercial | VIEW |
| 119. |  Frontage Laboratories (Shanghai) Co., Ltd. Shanghai, China | CRO | Commercial | VIEW |
| 120. |  Frontier Medicines South San Francisco, USA | Biotech | Phase 1/2 | VIEW |
| 121. |  Fusion Antibodies Belfast, Northern Ireland, United Kingdom | CRO | Discovery|Preclinical|Clinical (clients' projects) | VIEW |
| 122. |  Gene Oasis Singapore, Singapore | Biotech | Clinical | VIEW |
| 123. |  Genentech South San Francisco, California, United States | Biotech | Discovery through Commercial | VIEW |
| 124. |  Georgia Southern University Statesboro, USA | Biotech | Discovery | VIEW |
| 125. |  Gilead Sciences Foster City, California, United States | Pharma | Commercial | VIEW |
| 126. |  GlobalData Plc London, United Kingdom | Digital Health | Commercial | VIEW |
| 127. |  Google (Google DeepMind / Isomorphic Labs) London, United Kingdom | Biotech | Preclinical | VIEW |
| 128. |  Grünenthal Aachen, Germany | Pharma | Commercial | VIEW |
| 129. |  HBM Partners Zug, Switzerland | Biotech | Commercial | VIEW |
| 130. |  | CRO | Commercial | VIEW |
| 131. |  HCW Biologics Inc. Miramar, Florida, USA | Biotech | Phase 2 | VIEW |
| 132. |  HDS Formación Barcelona, Spain | Digital Health | Commercial | VIEW |
| 133. |  Halozyme Therapeutics San Diego, USA | Biotech | Commercial | VIEW |
| 134. |  Hansa Biopharma Lund, Sweden | Biotech | Commercial | VIEW |
| 135. |  Hanyang University Seoul, South Korea | Biotech | Phase 2 | VIEW |
| 136. |  | Pharma | Commercial | VIEW |
| 137. |  Hetero Healthcare Ltd Hyderabad, India | Pharma | Commercial | VIEW |
| 138. |  Hexal AG Holzkirchen, Germany | Pharma | Commercial | VIEW |
| 139. |  ICLOS-PDLC L'Hospitalet de Llobregat (Barcelona), Spain | CRO | N/A (Service Provider) | VIEW |
| 140. |  | CRO | Commercial | VIEW |
| 141. |  IKP Knowledge Park Hyderabad, India | CRO | Commercial | VIEW |
| 142. |  | Biotech | Phase 1/2 | VIEW |
| 143. |  IQVIA Durham, North Carolina, United States (Primary) / Danbury, Connecticut, United States (Secondary) | CRO | N/A - Service Provider | VIEW |
| 144. |  Idorsia Allschwil, Switzerland | Biotech | Commercial | VIEW |
| 145. |  Immundiagnostik AG Bensheim, Germany | Diagnostics | Commercial | VIEW |
| 146. |  Immuneel Therapeutics Bengaluru, India | Biotech | Commercial | VIEW |
| 147. |  Indian Immunologicals Limited Hyderabad, India | Biotech | Commercial | VIEW |
| 148. |  | CRO | Commercial | VIEW |
| 149. |  Intellia Therapeutics Cambridge, USA | Biotech | Phase 3 | VIEW |
| 150. |  Inttl Advocare New Delhi, India | CRO | Commercial | VIEW |
| 151. |  IntuitionLabs San Jose, California, USA | Digital Health | Commercial | VIEW |
| 152. |  Ionis Pharmaceuticals, Inc. Carlsbad, California, United States | Biotech | Phase 1 through Commercial | VIEW |
| 153. |  Italfarmaco Group Milan, Italy | Pharma | Commercial | VIEW |
| 154. |  JOINN Laboratories Beijing, China | CRO | Commercial | VIEW |
| 155. |  JW Pharmaceutical Gwacheon, South Korea | Pharma | Commercial | VIEW |
| 156. |  Janux Therapeutics San Diego, California, USA | Biotech | Phase 1 | VIEW |
| 157. |  Jiayue Pharmaceutical Guangzhou, China | Biotech | Phase 3 | VIEW |
| 158. |  Johnson & Johnson New Brunswick, New Jersey, USA | Pharma | Commercial | VIEW |
| 159. |  Johnson & Johnson New Brunswick, New Jersey, USA | Pharma | Discovery|Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 160. |  Junshi Biosciences Shanghai, China | Biotech | Commercial | VIEW |
| 161. |  KM Biologics Co., Ltd. Kumamoto, Japan | Biotech | Commercial | VIEW |
| 162. |  KMK Consulting Inc. Morristown, New Jersey, USA | CRO | Commercial | VIEW |
| 163. |  Keenova Therapeutics (formerly Endo Pharmaceuticals/Mallinckrodt Specialty Brands) Dublin, Ireland | Pharma | Commercial|Phase 1-3 | VIEW |
| 164. |  Khartis Therapeutics, Inc. San Diego, USA | Biotech | Discovery | VIEW |
| 165. |  Kinexum Harpers Ferry, USA | CRO | Commercial | VIEW |
| 166. |  Kiniksa Pharmaceuticals London, United Kingdom | Biotech | Commercial | VIEW |
| 167. |  Komtur Pharmaceuticals Freiburg, Germany | CRO | Commercial | VIEW |
| 168. |  Kowa Company, Ltd. Nagoya, Japan | Pharma | Commercial | VIEW |
| 169. |  Kyung Hee University Seoul, South Korea | Biotech | Phase 3 | VIEW |
| 170. |  LG Business Research Seoul, South Korea | Biotech | Commercial | VIEW |
| 171. |  Labcorp Burlington, North Carolina, USA | Diagnostics | Commercial | VIEW |
| 172. |  Laboratoires El Kendi Algiers, Algeria | CDMO | Commercial | VIEW |
| 173. |  Laboratoires Servier Orléans, France | Pharma | Preclinical through Commercial | VIEW |
| 174. |  Life Science Strategy Group Menlo Park, USA | CRO | Commercial | VIEW |
| 175. |  Lifespan (now Brown University Health) Providence, USA | Pharma | Commercial | VIEW |
| 176. |  | CDMO | Commercial | VIEW |
| 177. |  MARS Group Inc. Bloomington, Illinois, USA | CRO | Commercial | VIEW |
| 178. |  MK Bio Consultancy Oss, Netherlands | CRO | Commercial | VIEW |
| 179. |  MRH Regulatory Sciences San Francisco, USA | CRO | Commercial | VIEW |
| 180. |  MSD Rahway, New Jersey, USA | Pharma | Commercial | VIEW |
| 181. |  | Biotech | Commercial/Phase 3 | VIEW |
| 182. |  Medac Pharm / medac GmbH Wedel, Germany (near Hamburg) | Pharma | Commercial|Phase 2|Preclinical | VIEW |
| 183. |  Medison Pharma Petah Tikva, Israel | Biotech | Commercial | VIEW |
| 184. |  Mega Lifesciences Bangkok, Thailand | Pharma | Commercial | VIEW |
| 185. |  Merck & Co., Inc. Rahway, New Jersey, United States | Pharma | Phase 1-Phase 3 and Commercial | VIEW |
| 186. |  Merck KGaA, Darmstadt, Germany Darmstadt, Germany | Pharma | Commercial | VIEW |
| 187. |  MetaQ Trials Tel Aviv, Israel | Digital Health | Commercial | VIEW |
| 188. |  Miltenyi Biotec Bergisch Gladbach, Germany | Biotech | Commercial | VIEW |
| 189. |  | Biotech | Commercial | VIEW |
| 190. |  Mogam Institute for Biomedical Research Seoul, South Korea | Biotech | Discovery|Preclinical | VIEW |
| 191. |  | CRO | Commercial | VIEW |
| 192. |  NPDK Bioconsulting San Diego, California | CRO | Commercial | VIEW |
| 193. |  NextCure, Inc. Beltsville, Maryland, USA | Biotech | Phase 2 | VIEW |
| 194. |  Nexus Bio Sydney, Australia | Biotech | Commercial | VIEW |
| 195. |  Novartis Basel, Switzerland | Pharma | Phase 2, Phase 3, Commercial | VIEW |
| 196. |  Null Hypothesis Hangzhou, China | Digital Health | Commercial | VIEW |
| 197. |  ONO PHARMA UK LTD London, United Kingdom | Pharma | Phase 1 through Commercial | VIEW |
| 198. |  ONO Pharmaceutical Osaka, Japan (Chuo-ku) | Pharma | Phase 1-Phase 3 | VIEW |
| 199. |  Oceanus Plus Beijing, China | Digital Health | Commercial | VIEW |
| 200. |  On/Off Therapeutics Paris, France | Biotech | Preclinical | VIEW |
| 201. |  Orchard Therapeutics London, United Kingdom | Biotech | Commercial | VIEW |
| 202. |  Otsuka Pharmaceutical Chiyoda, Tokyo, Japan | Pharma | Phase 1 through Commercial | VIEW |
| 203. |  | Pharma | Commercial | VIEW |
| 204. |  PPD (Pharmaceutical Product Development) Wilmington, North Carolina, USA | CRO | Commercial | VIEW |
| 205. |  Parexel Raleigh, North Carolina, USA | CRO | Phase I-IV (as a CRO, Parexel manages client pipelines, not its own) | VIEW |
| 206. |  Partex NV Eschborn, Germany | Biotech | Phase 2 | VIEW |
| 207. |  Parvus Therapeutics South San Francisco, USA | Biotech | Phase 1/2 | VIEW |
| 208. |  PharmaBlock Sciences (Nanjing), Inc. Nanjing, China | CDMO | Commercial | VIEW |
| 209. |  PicnicHealth San Francisco, USA | Digital Health | Commercial | VIEW |
| 210. |  Platinum Life Excellence Biotech Beijing, China | Biotech | Commercial | VIEW |
| 211. |  Policlinico Gemelli Rome, Italy | CRO | Commercial | VIEW |
| 212. |  Prana Biosciences Worcester, USA | Biotech | Preclinical | VIEW |
| 213. |  Precision Medicine Group Bethesda, USA | CRO | Commercial | VIEW |
| 214. |  Precision for Medicine Bethesda, Maryland, USA | CRO | Commercial | VIEW |
| 215. |  Process Automation Solutions (PA) Ludwigshafen, Germany / Greenville, SC, USA | CDMO | Commercial | VIEW |
| 216. |  Quell Therapeutics London, United Kingdom | Biotech | Phase 2 | VIEW |
| 217. |  | Biotech | Phase 2 | VIEW |
| 218. |  | Biotech | Phase 1 | VIEW |
| 219. |  Rho Durham, North Carolina, USA | CRO | Commercial | VIEW |
| 220. |  Ridgeline Discovery Basel, Switzerland | Biotech | Discovery|Preclinical|Phase 1|Phase 2 | VIEW |
| 221. |  | Pharma | Discovery|Preclinical|Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 222. |  | Pharma | Commercial | VIEW |
| 223. |  Rondo Therapeutics Hayward, USA | Biotech | Phase 1 | VIEW |
| 224. |  STADA Arzneimittel AG Bad Vilbel, Germany | Pharma | Commercial | VIEW |
| 225. |  STADA Arzneimittel AG Bad Vilbel, Germany | Pharma | Commercial | VIEW |
| 226. |  SYFM Co., Ltd. Seoul, South Korea | CDMO | Commercial | VIEW |
| 227. |  Saama Technologies Campbell, USA | Digital Health | Commercial | VIEW |
| 228. |  Sai Life Sciences Hyderabad, India | CDMO | Commercial | VIEW |
| 229. |  Sandoz Group AG Basel, Switzerland | Pharma | Commercial | VIEW |
| 230. |  | Pharma | Preclinical through Phase 3 | VIEW |
| 231. |  Scenic Biotech Amsterdam, The Netherlands | Biotech | Preclinical to IND-enabling | VIEW |
| 232. |  Selvita S.A. Krakow, Poland | CRO | Discovery | VIEW |
| 233. |  Senti Biosciences South San Francisco, California, USA | Biotech | Phase 1 | VIEW |
| 234. |  Shanghai Jeyou Pharmaceutical Co., Ltd. Shanghai, China (Pudong district) | Biotech | Preclinical to Phase 2 | VIEW |
| 235. |  | Pharma | Commercial | VIEW |
| 236. |  Sopharma AD Sofia, Bulgaria | Pharma | Commercial | VIEW |
| 237. |  Syneos Health Morrisville, North Carolina, USA | CRO | Not applicable - Syneos Health supports client pipelines across all stages (Discovery to Commercial) | VIEW |
| 238. |  Syngene International Bengaluru, India | CRO | Commercial | VIEW |
| 239. |  TRG Ventures Hellerup, Denmark | Biotech | Phase 3 | VIEW |
| 240. |  TYG Oncology Mansfield, Nottinghamshire, United Kingdom | Biotech | Phase 1 | VIEW |
| 241. |  Takeda Pharmaceutical Company Tokyo, Japan | Pharma | Phase 3 | VIEW |
| 242. |  Tanabe Pharma Corporation Osaka, Japan | Pharma | Commercial | VIEW |
| 243. |  Tata Consultancy Services Mumbai, India | CRO | Commercial | VIEW |
| 244. |  Thermo Fisher Scientific Waltham, Massachusetts, United States | CRO | Full spectrum - from drug discovery through Phase I-III and commercial | VIEW |
| 245. |  Travalcon Scarborough, Canada | Digital Health | Commercial | VIEW |
| 246. |  TrialBlaze Wilmington, North Carolina, USA | CRO | Commercial | VIEW |
| 247. |  U.S. Stem Cell, Inc. Sunrise, Florida, United States | Biotech | Clinical Development | VIEW |
| 248. |  University of California, Berkeley Berkeley, USA | Biotech | Discovery | VIEW |
| 249. |  University of Cincinnati Cincinnati, USA | Biotech | Commercial | VIEW |
| 250. |  University of Colorado Boulder Boulder, USA | Biotech | Discovery | VIEW |
| 251. |  University of Essex Colchester, United Kingdom | Biotech | Discovery | VIEW |
| 252. |  University of Wisconsin–Madison Madison, USA | Biotech | Commercial | VIEW |
| 253. |  Vaarunya Biolabs Bengaluru, India | CRO | Commercial | VIEW |
| 254. |  Vaxcyte San Carlos, California, USA | Biotech | Clinical (Phase 2 and Phase 3) | VIEW |
| 255. |  Viatris Canonsburg, Pennsylvania, United States | Pharma | Phase 1 to Commercial | VIEW |
| 256. |  | Biotech | Phase 3 | VIEW |
| 257. |  WriteSource Medical Pty Ltd North Sydney, Australia | CRO | Commercial | VIEW |
| 258. |  X4 Pharmaceuticals Boston, USA | Biotech | Commercial | VIEW |
| 259. |  Xilio Therapeutics Waltham, Massachusetts | Biotech | Phase 2 | VIEW |
| 260. |  Yasham Specialty Ingredients Pvt Ltd Mumbai, India | CDMO | Commercial | VIEW |
| 261. |  Zydus Lifesciences Limited Ahmedabad, India | Pharma | Phase 1|Phase 2|Phase 3|Commercial | VIEW |
| 262. |  arGenX (argenx) Amsterdam, Netherlands | Biotech | Phase 1 through Commercial | VIEW |
| 263. |  | CDMO | Commercial | VIEW |